• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

9-氨基吖啶药物奎纳克林与谷胱甘肽的反应性限制了其抗朊病毒活性。

Reactivity of 9-aminoacridine drug quinacrine with glutathione limits its antiprion activity.

作者信息

Šafařík Martin, Moško Tibor, Zawada Zbigniew, Šafaříková Eva, Dračínský Martin, Holada Karel, Šebestík Jaroslav

机构信息

Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague 6, Czech Republic.

First Faculty of Medicine, Institute of Immunology and Microbiology, Charles University in Prague, Prague 2, Czech Republic.

出版信息

Chem Biol Drug Des. 2017 Jun;89(6):932-942. doi: 10.1111/cbdd.12918. Epub 2017 Jan 25.

DOI:10.1111/cbdd.12918
PMID:27933730
Abstract

Quinacrine-the drug based on 9-aminoacridine-failed in clinical trials for prion diseases, whereas it was active in in vitro studies. We hypothesize that aromatic nucleophilic substitution at C9 could be contributing factor responsible for this failure because of the transfer of acridine moiety from quinacrine to abundant glutathione. Here, we described the semi-large-scale synthesis of the acridinylated glutathione and the consequences of its formation on biological and biophysical activities. The acridinylated glutathione is one order of magnitude weaker prion protein binder than the parent quinacrine. Moreover, according to log D , the glutathione conjugate is two orders of magnitude more hydrophilic than quinacrine. Its higher hydrophilicity and higher dsDNA binding potency will significantly decrease its bioavailability in membrane-like environment. The glutathione deactivates quinacrine not only directly but also decreases its bioavailability. Furthermore, the conjugate can spontaneously decompose to practically insoluble acridone, which is precipitated out from the living systems.

摘要

喹吖因——一种基于9-氨基吖啶的药物——在朊病毒疾病的临床试验中失败了,尽管它在体外研究中具有活性。我们推测,由于吖啶部分从喹吖因转移到大量存在的谷胱甘肽,C9位的芳环亲核取代可能是导致这种失败的一个因素。在此,我们描述了吖啶化谷胱甘肽的半大规模合成及其形成对生物和生物物理活性的影响。吖啶化谷胱甘肽与朊病毒蛋白结合的能力比母体喹吖因弱一个数量级。此外,根据分配系数,谷胱甘肽共轭物的亲水性比喹吖因高两个数量级。其更高的亲水性和更高的双链DNA结合能力将显著降低其在膜状环境中的生物利用度。谷胱甘肽不仅直接使喹吖因失活,还降低其生物利用度。此外,共轭物可自发分解为几乎不溶的吖啶酮,从生物系统中沉淀出来。

相似文献

1
Reactivity of 9-aminoacridine drug quinacrine with glutathione limits its antiprion activity.9-氨基吖啶药物奎纳克林与谷胱甘肽的反应性限制了其抗朊病毒活性。
Chem Biol Drug Des. 2017 Jun;89(6):932-942. doi: 10.1111/cbdd.12918. Epub 2017 Jan 25.
2
Prion inhibition with multivalent PrPSc binding compounds.用多价 PrPSc 结合化合物抑制朊病毒。
Biomaterials. 2012 Oct;33(28):6808-22. doi: 10.1016/j.biomaterials.2012.06.004. Epub 2012 Jun 28.
3
Anti-prion activities and drug-like potential of functionalized quinacrine analogs with basic phenyl residues at the 9-amino position.9-氨基位置带有碱性苯基残基的功能化喹吖因类似物的抗朊病毒活性及类药物潜力。
Eur J Med Chem. 2011 Jul;46(7):2917-29. doi: 10.1016/j.ejmech.2011.04.016. Epub 2011 Apr 12.
4
Antiprion activity of functionalized 9-aminoacridines related to quinacrine.与奎纳克林相关的功能化9-氨基吖啶的抗朊病毒活性。
Bioorg Med Chem. 2008 Jul 15;16(14):6737-46. doi: 10.1016/j.bmc.2008.05.060. Epub 2008 Jun 13.
5
Chelating compound, chrysoidine, is more effective in both antiprion activity and brain endothelial permeability than quinacrine.螯合化合物金胺在抗朊病毒活性和脑内皮通透性方面都比奎纳克林更有效。
Cell Mol Neurobiol. 2007 May;27(3):303-16. doi: 10.1007/s10571-006-9122-0. Epub 2007 Jan 19.
6
Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments.三环类抗抑郁药、奎纳克林及其新型合成嵌合体通过破坏抗去污剂膜区室来清除朊病毒。
J Neurochem. 2006 Aug;98(3):748-59. doi: 10.1111/j.1471-4159.2006.03889.x. Epub 2006 Jun 2.
7
Acridin-9-yl exchange: a proposal for the action of some 9-aminoacridine drugs.吖啶-9-基交换:关于某些9-氨基吖啶药物作用的一种假说。
Biopolymers. 2006;84(6):605-14. doi: 10.1002/bip.20590.
8
Continuous quinacrine treatment results in the formation of drug-resistant prions.连续 quinacrine 治疗会导致产生耐药性朊病毒。
PLoS Pathog. 2009 Nov;5(11):e1000673. doi: 10.1371/journal.ppat.1000673. Epub 2009 Nov 26.
9
A chimeric ligand approach leading to potent antiprion active acridine derivatives: design, synthesis, and biological investigations.一种产生强效抗朊病毒活性吖啶衍生物的嵌合配体方法:设计、合成及生物学研究。
J Med Chem. 2006 Nov 2;49(22):6591-5. doi: 10.1021/jm060773j.
10
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease.吖啶和吩噻嗪衍生物作为朊病毒病的药物治疗剂。
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9836-41. doi: 10.1073/pnas.161274798.

引用本文的文献

1
Calf Thymus DNA Exposed to Quinacrine at Physiological Temperatures and pH Acquires Immunogenicity: A Threat for Long Term Quinacrine Therapy.在生理温度和pH值下暴露于喹吖因的小牛胸腺DNA获得免疫原性:对喹吖因长期治疗的一种威胁。
Indian J Clin Biochem. 2022 Oct;37(4):441-448. doi: 10.1007/s12291-021-01013-9. Epub 2021 Oct 20.
2
Identifying Anti-prion Chemical Compounds Using a Newly Established Yeast High-Throughput Screening System.利用新建立的酵母高通量筛选系统鉴定抗朊病毒化学化合物。
Cell Chem Biol. 2019 Dec 19;26(12):1664-1680.e4. doi: 10.1016/j.chembiol.2019.10.004. Epub 2019 Oct 23.